A recent study identified low levels of L-octanoylcarnitine as a biomarker of breast cancer (100% positive predictive value) against samples from healthy individuals, in addition to presenting different levels depending on the size of the tumor, as well as high abundance in tumors with high expression of estrogen and progesterone receptors [40]. Here, PGR is linked to breast cancer.